There's a particular kind of frustration that comes from doing everything right and still getting the wrong result.

We had been gluten-free for almost a year. I had cleared out the pantry shelf by shelf. I had read ingredient lists on things I never imagined needed reading - soy sauce, salad dressing, oat packages, even some spice blends. I had found cleaner versions of our family's favorite comfort foods. My daughter's symptoms had finally, finally started to settle down.

Then she got a sinus infection. We filled a prescription. And within two days, she was back to that bloated, exhausted, foggy version of herself that I had spent months trying to help her move past.

I went through everything she had eaten. Nothing flagged. I checked and rechecked. And then, almost as an afterthought, I picked up that little orange prescription bottle and started wondering.

What followed was one of the more unsettling research experiences I've had as a parent - not because the information was hard to find, but because of what it revealed. There's a genuine, structural gap between how the food system protects people with gluten sensitivities and how the pharmaceutical system does. That gap has a history, a logic, and real consequences for families like mine.

This is what I learned.

Two Completely Different Rule Books

Let me start with what struck me as almost absurd once I understood it.

In 2013, the FDA finalized a rule requiring that any food product labeled "gluten-free" contain fewer than 20 parts per million of gluten. That threshold came from research on what the celiac disease community could reasonably tolerate. It's a real, enforceable standard. Food manufacturers have to meet it or they can't use the label.

Pharmaceutical products? An entirely different framework - or more accurately, the near-absence of one.

The FDA does not require drug manufacturers to disclose gluten on drug labels. The ingredients most likely to introduce gluten into a medication - starches, modified starches, dextrin - are classified as excipients, which is the pharmaceutical term for inactive ingredients. The reasoning has always been that they don't have therapeutic effects. They're just the vehicle. They hold the pill together, help it dissolve, give it a coating.

For most people, that logic holds. For someone with celiac disease or significant gluten sensitivity, the vehicle absolutely matters.

What really stopped me in my tracks was the timing. Research published in Gastroenterology in 2013 - the same year the food labeling rule was finalized - specifically noted that while food labeling had moved forward, no equivalent requirement existed for pharmaceutical products, and that gluten-containing excipients appear across a wide range of medications, including over-the-counter options. The same year. Two different systems, moving in two different directions.

How We Got Here: A Story About Outdated Assumptions

I'm someone who needs to understand the why behind things, so I kept digging. Why does this gap exist? The answer turned out to be a story about assumptions that made sense once and then calcified into policy long after the science moved on.

Pharmaceutical excipients have been classified as "inactive" since long before celiac disease was well understood as an autoimmune condition. For much of the 20th century, celiac disease was considered rare, difficult to diagnose, and not particularly well mapped in medical literature. Wheat starch became a standard pharmaceutical ingredient because it was cheap, stable, widely available, and had reliable binding properties. The people making those formulation decisions weren't thinking about gluten sensitivity - because at the time, the medical community wasn't thinking much about it either.

Then the science shifted, dramatically. We now understand that celiac disease affects roughly 1 in 100 people worldwide. Research on non-celiac gluten sensitivity has expanded the picture even further, suggesting that a much larger portion of the population may experience meaningful reactions to gluten without meeting the full diagnostic criteria for celiac disease. The population that needs protection is significantly larger than anyone imagined when these pharmaceutical standards were being written.

The standards, though, largely didn't update to reflect that. What we're left with is a labeling framework built on mid-century assumptions about which ingredients are "relevant," applied to families navigating a condition that science now takes far more seriously. That's not a conspiracy. It's institutional inertia. But it has real effects on real families.

What's Actually in There: Getting Specific

I want to go through the ingredients that matter here, because specificity is what makes this information actually usable. The excipients most likely to contain gluten in medications include:

• Starch - Used widely as a binder, filler, and disintegrant in tablets and capsules. It can be derived from corn, potato, rice, or wheat, and the label frequently does not specify which.
• Pregelatinized starch - A modified form processed for improved binding. The same ambiguity around grain source applies.
• Dextrin and maltodextrin - Derived from starch hydrolysis. In the U.S., maltodextrin is more commonly corn-derived, but the source isn't guaranteed, and dextrin can absolutely come from wheat.
• Tablet coatings - An area that gets less attention than internal ingredients, but some coatings use wheat-derived materials.

A 2012 study published in Mayo Clinic Proceedings examined oral medications sold in the U.S. and found that while most did not contain gluten in amounts likely to cause harm, a meaningful number had ambiguous labeling or unlisted wheat-derived ingredients. The researchers concluded that clinicians should be aware that some medications may contain gluten.

That word may is doing a lot of work in that sentence. For a family trying to maintain a genuinely gluten-free environment, "may contain" isn't a reassurance. It's a flag.

The Generic Switch Problem Nobody Talks About

Here's where things get more complicated - and where I think a lot of families get blindsided without ever knowing why.

Brand-name and generic versions of the same drug can have completely different inactive ingredients. When a generic is approved, it has to match the active ingredient and demonstrate bioequivalence - meaning it delivers the drug to the body in a comparable way. The excipients? Those can be entirely different.

This matters enormously for gluten-free families because medication switches happen constantly, often without any announcement. Insurance formularies change. Pharmacies switch suppliers. You refill the same prescription you've been taking for two years, the pill looks slightly different, and nobody mentions it.

There are documented cases in medical literature of patients with celiac disease who had been stable for years before experiencing a return of symptoms traced - after considerable detective work - to a change in their medication's formulation. One case involved a patient whose thyroid medication changed its starch source when switching to a generic, triggering a return of symptoms that had taken months to quiet down.

I found that both vindicating and infuriating. Vindicating because it confirmed this is a real phenomenon, not a parent being anxious. Infuriating because of how much investigation fell entirely on the patient to figure out.

The Burden Lands on Families - And That's Not Okay

I want to be honest about what navigating this actually looks like day to day, because I think it helps to know what you're walking into.

To find out whether a specific medication contains gluten, here's what you're essentially expected to do:

1. Track down the full inactive ingredient list - often not on the packaging itself, but buried in prescribing information or on the manufacturer's website.
2. Identify any starch-based or starch-derived excipients in that list.
3. Contact the manufacturer directly to ask about the grain source of those specific ingredients.
4. Accept that the answer may be some version of "we can't guarantee it's wheat-free," even when the actual risk is probably low.

That is a significant amount of work. And it falls almost entirely on patients and caregivers - not on the companies formulating the product, and not on a regulatory structure that requires them to disclose it.

The comparison that keeps coming back to me: I can walk into any grocery store and find a food label that tells me, with the backing of federal regulation, whether a product meets a gluten-free standard. I cannot walk into a pharmacy and receive that same clarity about a prescription drug. We have built a system where the most detailed food labeling in history coexists with pharmaceutical labeling that hasn't meaningfully evolved to address the same concern.

What Has Actually Helped Us

I don't want this to be only a problem post, so let me share what has genuinely moved the needle for our family.

• Calling the manufacturer's medical information line. This surprised me more than anything. Most pharmaceutical companies have a dedicated line for healthcare inquiries, and when I've asked specific questions about starch sources, I've often gotten real answers. Not always satisfying ones, but real ones. It takes time, but it beats guessing.
• Actually talking to our pharmacist. A good pharmacist is an underused resource here. They often have access to ingredient databases that go beyond what's on the packaging, and they can sometimes identify whether a compounding pharmacy could prepare a gluten-free version of a specific medication. I didn't know compounding was an option until I asked directly.
• Keeping a symptom journal. Low-tech, but this is what connected the dots for us. When the food side looked clean and something still felt off, tracking timing around new or changed medications gave us a thread to follow. Vague patterns become legible information when you write them down consistently.
• The University of Chicago Celiac Disease Center has published guidance on medications and celiac disease written for patients and families, not just clinicians. It's worth having bookmarked as a reference.

Where This Is All Heading

I try not to be purely reactive in my research - I want to understand where things are moving, not just where they've been stuck.

There are some reasons for measured optimism. Market pressure is doing work that regulation hasn't done yet. Some over-the-counter manufacturers are now proactively labeling products as gluten-free because enough consumers are asking for that clarity. That's not a systemic fix, but it's evidence that sustained demand shapes behavior even when formal rules lag behind.

There are also conversations happening within celiac advocacy communities and gastroenterology research about pushing toward clearer FDA disclosure requirements for pharmaceutical excipients. Whether that gains traction depends on advocacy, research visibility, and enough families continuing to make noise about it. We're not there yet, but the conversation is at least happening.

The longer-horizon possibility I find genuinely interesting is the intersection of personalized medicine and formulation science. As pharmacogenomics develops - the science of how individual genetics affect drug responses - there's a plausible future where medications are formulated with far more specificity around individual patient profiles, including dietary requirements. That's a longer arc, but the direction is right.

What This Has to Do with How We Eat

I realize this has been a post about medicine, and this might seem like an odd place to bring food back in. But for me, these things connect at a fundamental level.

The reason I work as hard as I do on what our family eats - prioritizing clean ingredients, reading every label, choosing organic where it matters - is because I believe the whole picture matters. It doesn't make sense to put real effort into sourcing clean food and then introduce unexamined uncertainty through a pill bottle. The same principle applies everywhere: you deserve to know what's actually in the thing you're putting into your body.

That philosophy is part of why something like Clean Monday Meals resonates with me. Organic ramen noodles with clean seasoning, real ingredients you can actually recognize - it reflects an approach to food that takes ingredient transparency seriously. When that becomes your baseline standard for food, it naturally raises your expectations for everything else, including what's sitting on your bathroom shelf.

The One Thing I'd Tell My Earlier Self

If I could go back to the beginning of our gluten-free journey and add one thing to my orientation, it would be this: "inactive" does not mean "irrelevant."

That classification was designed around a framework that predates our current understanding of gluten-related disorders. It wasn't built with families like ours in mind. That's not a reason to distrust medicine - not even close. But it is a reason to bring the same curiosity and persistence to your medicine cabinet that you've already learned to bring to your pantry.

Ask questions. Call manufacturers. Find a pharmacist who takes this seriously. Keep notes. And know that the investigation is worth doing - because it is.

When something still feels off even though everything looks clean on the food side, don't rule out the little orange bottle.

Everything shared here reflects my own research and experience navigating a gluten-free household. None of this is medical advice, and it's not meant to replace conversations with your child's doctor or pharmacist. When in doubt, always bring your questions to a qualified healthcare provider.